சர்வதேச முதலீட்டாளர் உறவுகள் தொடர்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச முதலீட்டாளர் உறவுகள் தொடர்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச முதலீட்டாளர் உறவுகள் தொடர்பு Today - Breaking & Trending Today

EyeLock Secures Contract in Egypt with its Portable Template Technology


EyeLock Secures Contract in Egypt with its Portable Template Technology
USA - English
Share this article
Share this article
NEW YORK, April 21, 2021 /PRNewswire/  EyeLock LLC, a leader of iris  identity authentication solutions and subsidiary of VOXX International Corporation (NASDAQ: VOXX), announced today that it was awarded a contract to control the access of individuals into the four data center facilities responsible for the monitoring and control of all governmental buildings, streets and all services providers for the New Capital City of Egypt.
EyeLock s recently introduced, Portable Template solution was selected due to its ability to provide a highly secure and accurate iris biometric solution and protect the user s personally identifiable information (PII).  ....

Larissa Goulding , Glenn Wiener , Marco Emrich , International Business Development , International Corporation , International Media Contact , Consumer Electronics , Bluetooth Low Energy , International Investor Relations Contact , Automotive Electronics , New Capital City , Portable Template , Vice President , Investor Relations Contact , லாரிசா கூல்டிஂக் , க்ளென் வீனர் , சர்வதேச வணிக வளர்ச்சி , சர்வதேச நிறுவனம் , சர்வதேச மீடியா தொடர்பு , நுகர்வோர் மின்னணுவியல் , புளூடூத் குறைந்த ஆற்றல் , சர்வதேச முதலீட்டாளர் உறவுகள் தொடர்பு , தானியங்கி மின்னணுவியல் , புதியது மூலதனம் நகரம் , துணை ப்ரெஸிடெஂட் , முதலீட்டாளர் உறவுகள் தொடர்பு ,

BetterLife's Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application


BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
VANCOUVER, Dec. 14, 2020 BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.” 
While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled en ....

United States , British Columbia , Patrick Kroupa , Ahmad Doroudian , Dost Mustaq , No Securities Exchange , Betterlife Pharma Inc , United Nations , Neither The Canadian Securities Exchange , Canadian Securities Exchange , International Investor Relations Contact , Transcend Biodynamics , Betterlife Pharma , American Journal , Controlled Substance , Controlled Substance Act , Chief Executive Officer , Qlife Pharma , Chief Executive Officer Email , Investor Relations Contact Email , Market Regulator , Securities Exchange , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , பேட்ரிக் க்ரோபா , டாஸ்ட் மஸ்டேக் ,

BetterLife's Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application


Share:
VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) BetterLife Pharma Inc. ( BetterLife or the Company ) (CSE:BETR, OTCQB:BETRF), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC s ( Transcend ) manufacturing patent Process of synthesizing 2-Bromo-LSD.  
While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled enforcement status and global United Nations drug conventions of which the United States and Canada are both participants. Authors of ....

United States , British Columbia , Patrick Kroupa , Ahmad Doroudian , Dost Mustaq , Betterlife Pharma Inc , United Nations , Neither The Canadian Securities Exchange , Canadian Securities Exchange , International Investor Relations Contact , Transcend Biodynamics , Qlife Pharma , American Journal , Controlled Substance , Controlled Substance Act , Chief Executive Officer , Chief Executive , Investor Relations Contact , Market Regulator , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , பேட்ரிக் க்ரோபா , டாஸ்ட் மஸ்டேக் , ஒன்றுபட்டது நாடுகள் , இல்லை தி கனடியன் பத்திரங்கள் பரிமாற்றம் , கனடியன் பத்திரங்கள் பரிமாற்றம் ,